A Preliminary Risk-Benefit Assessment of Latanoprost and Unoprostone in Open-Angle Glaucoma and Ocular Hypertension

被引：0
|
作者：
Dan L. Eisenberg
Carl B. Camras
机构：
[1] University of Nebraska Medical Center,Department of Ophthalmology
[2] 985540 Nebraska Medical Center,undefined
来源：
Drug Safety | 1999年 / 20卷
关键词：
Glaucoma; Adis International Limited; Intraocular Pressure; Timolol; Latanoprost;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Latanoprost and unoprostone (isopropyl unoprostone) represent the first commercially available prostaglandin analogues to be used for the treatment of glaucoma. Both compounds reduce intraocular pressure by enhancing uveoscleral outflow.
引用
收藏
页码：505 / 514
页数：9
相关论文
共 50 条
  • [1] A preliminary risk-benefit assessment of latanoprost and unoprostone in open-angle glaucoma and ocular hypertension
    Eisenberg, DL
    Camras, CB
    DRUG SAFETY, 1999, 20 (06) : 505 - 514
  • [2] A comparative clinical study of latanoprost and isopropyl unoprostone in Japanese patients with primary open-angle glaucoma and ocular hypertension
    Tsukamoto, H
    Mishima, HK
    Kitazawa, Y
    Araie, M
    Abe, H
    Negi, A
    JOURNAL OF GLAUCOMA, 2002, 11 (06) : 497 - 501
  • [3] A double-masked, randomized clinical trial comparing latanoprost with unoprostone in patients with open-angle glaucoma or ocular hypertension
    Susanna, R
    Giampani, J
    Borges, AS
    Vessani, RM
    Jordao, MLS
    OPHTHALMOLOGY, 2001, 108 (02) : 259 - 263
  • [4] Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension
    Netland, PA
    Landry, T
    Sullivan, EK
    Andrew, R
    Silver, L
    Weiner, A
    Mallick, S
    Dickerson, J
    Bergamini, MVW
    Robertson, SM
    Davis, AA
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2001, 132 (04) : 472 - 484
  • [5] Effects of latanoprost and unoprostone when used alone or in combination for open-angle glaucoma
    Saito, M
    Takano, R
    Shirato, S
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2001, 132 (04) : 485 - 489
  • [6] Comparative effects of latanoprost (Xalatan) and unoprostone (Rescula) in patients with open-angle glaucoma and suspected glaucoma
    Sponsel, WE
    Paris, G
    Trigo, Y
    Pena, M
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2002, 134 (04) : 552 - 559
  • [7] Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension - Reply
    Netland, PA
    Landry, T
    Sullivan, EK
    Andrew, R
    Silver, L
    Weiner, A
    Mallick, S
    Dickerson, J
    Bergamini, MVW
    Robertson, SM
    Davis, AA
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2002, 133 (05) : 732 - 733
  • [8] A randomized double-masked crossover study comparing latanoprost 0.005% with unoprostone 0.12% in patients with primary open-angle glaucoma and ocular hypertension
    Aung, T
    Chew, PTK
    Yip, CC
    Chan, YH
    See, JLS
    Khng, CC
    Hoh, ST
    Ng, LH
    Lee, HM
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2001, 131 (05) : 636 - 642
  • [9] OCULAR HYPERTENSION OR EARLY GLAUCOMA - OCULAR HYPERTENSION VS OPEN-ANGLE GLAUCOMA
    CHANDLER, PA
    GRANT, WM
    ARCHIVES OF OPHTHALMOLOGY, 1977, 95 (04) : 585 - 586
  • [10] Additive ocular hypotensive effect of latanoprost and unoprostone in patients with open angle glaucoma.
    Kiuchi, Y
    Fukui, K
    Ohnishi, T
    Hayashida, Y
    Ichiro, I
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S819 - S819
12345